Drug search by name

Peginterferon Alfa-2b (Sylatron) and Diabetes mellitus

Result of checking the interaction of drug Peginterferon Alfa-2b (Sylatron) and disease Diabetes mellitus for safety when used together.

Check result:

Peginterferon Alfa-2b (Sylatron) <> Diabetes mellitus

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Flu-like symptoms frequently associated with interferon-alfa therapy can precipitate ketoacidosis in diabetic patients. Therapy with interferon alfa should be administered cautiously in patients with diabetes mellitus. Clinical monitoring of blood glucose concentrations and anti-diabetic therapy is recommended.

References:

"Product Information. Infergen (interferon alfacon-1)." Amgen, Thousand Oaks, CA.
"Product Information. Intron A (interferon alfa-2b)." Schering Laboratories, Kenilworth, NJ.

Peginterferon Alfa-2b (Sylatron)

Generic Name: peginterferon alfa-2b

Brand Name: PegIntron, Sylatron, PegIntron Redipen

Synonyms: Peginterferon alfa-2b, Peginterferon Alfa-2b

What is Peginterferon Alfa-2b (Sylatron)?